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Background: Nasojejunal tube (NJT) decompression is routinely used for intestinal drainage after total
gastrectomy. It is supposed that it would protect anastomosis, but since the stomach should be
completely removed, today its efﬁcacy is under question. On the other hand, the tube leads to the
discomfort of patients and aspiration disorders or nasopharyngial ulceration. The aim of this study was to
evaluate the efﬁcacy and necessity of the nasojejunal tube decompression after gastrectomy.
Methods: In this interventional study, 50 gastric cancer patients who underwent gastrectomy in Ghaem
and Omid hospitals, which are afﬁliated with the Mashhad University of Medical Sciences, from 2001 to
2008 were enrolled. The patients were randomly divided into two groups of with NJT (25 cases) and
without NJT (25 cases). The rate of complications, hospital stay duration and the time of beginning their
diet were evaluated.
Results: The two groups were similar in age, sex, state of the disease, bleeding volume and length of
removed esophagus. There was no signiﬁcant difference between these two groups considering the
initial passing of gas, the beginning of their diet, and hospital stay duration. But the incidence of sore
throat, nasal discomfort, speech disorders, and patients’ dissatisfation were higher in the group with NJT.
Conclusion: It seems that patients without NJT were more comfortable and satisﬁed after total gastrec-
tomy. Thus, there is no need for the insertion of the NJT after gastrectomy.
 2011 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Using a nasojejunal tube (NJT) for the evacuation of gas and ﬂuid
goes back to more than 300 years ago and its indications for use
have been for treatment (abdominal distention, and vomiting in
bowel obstruction), diagnosis (upper gastrointestinal bleeding) or
prophylaxis (ileus in major abdominal operations). Additionally, in
the past few decades, using a nasogastric tube has become common
in many major abdominal surgeries. For example, the insertion of
a nasogastric or nasojejunal tube for the protection of anastomosis
or prevention of ileus after gastrectomy have been routinely rec-
ommended and used; but recently, their beneﬁts for decompres-
sion is under question, and it has been reported that it increases
discomfort for patients and the rate of respiratory complications.1e8
A prospective randomized trial has suggested that there is no need
for the nasogastric or nasojejunal tube after gastrectomy.9 More-
over, Yang et al. in a meta-analysis study reported that routine
nasogastric or nasojejunal decompression is unnecessary after
gastrectomy for gastric cancer.10 On the other hand, Montgomery12806; fax: þ98 5118402972.
ciates Ltd. Published by Elsevier Ltet al. in 1996 have described the decompression tubes as standard
of care after gastrectomy.11 However, to our knowledge, there is no
prospective study in this ﬁeld in Iran. The aim of this study was to
evaluate the efﬁcacy and necessity of the nasojejunal tube after
gastrectomy.
2. Materials and methods
This interventional study was performed on 50 patients who underwent total
gastrectomy in the afﬁliated Mashhad University of Medical Sciences hospitals,
Ghaem and Omid, from 2001 to 2008. Additionally, the Ethical Committee of the
Mashhad University of Medical Sciences approved this study.
Patients with a history of abdominal irradiation, emergency surgery, technical
operative difﬁculties (duodenal, pancreatic or vascular injury), and additional resection
of adjacent organs were excluded from this study. The conditions of the study were
completely explained to the patients and then informed written consent was taken
from them.
For patients undergoing gastrectomy, a radical lymphadenectomy without
splenectomy and pancreatectomy was performed for those with a malignancy.
Digestive continuity wasmaintained by Roux-en-y esophagojejunal anastomosis. All
of the patients with gastric adenocarcinoma underwent total gastrectomy and
radical lymphadenectomy (D2 Resection). Then, the patients were randomly divided
into two groups: group 1 (25 patients) received a nasojejunal tube, and group 2 (25
patients) postoperatively did not receive a nasojejunal tube. In the ﬁrst group, the
tube was removed at least 36 h after operation for continuous drainage until
the passage of ﬂatus or stool. In the second group, the tube was removed when the
patient was in the recovery room. Oral intake was restricted for all patients afterd. All rights reserved.
Table 1
Patients’ demographic and operative characteristics.
Characteristics Without
NJT (n¼ 25)
With
NJT (n¼ 25)
P-value
Age (yr) 56.12 12.94 58.4 12.09 0.812
Sex (M) (N%) 16 (64%) 17 (68%) 0.542
Operative time (h) 3.78 0.61 3.73 0.44 0.671
Intraoperative blood loss (ml) 604 76.21 495.6 50.4 0.257
Need for transfusion 7 (28%) 10 (40%) 0.529
Length of distal
esophageal resection (cm)
2.11 0.82 1.9 0.84 0.197
BMI 18.1 1.18 20.0 0.59 0.079
Chart 1. Percent of bloating in patients with NJT and without NJT.
A. Tavassoli et al. / International Journal of Surgery 9 (2011) 233e236234
ORIGINAL RESEARCHthe operation until the passage of ﬂatus in the absence of abdominal distension,
nausea or vomiting. Patients were allowed to drink clear water after resolution of
the ileus, and then they progressed to a liquid and a semi-solid diet when they were
able to tolerate water for more than 24 h. In group 1, the tube was removed after the
passage of ﬂatus, and patients were allowed to drink water about 6 h later. The diet
for the two groups progressed similarly, from clear liquids to soft foods, as tolerated.
In group 2, a nasojejunal tube was inserted, or reinserted only if a patient developed
a clinical need for decompression (i.e., repeated episodes of vomiting or abdominal
distension), as determined during the postoperative period. All patients received
a short-term preoperative antibiotic prophylaxis with a third-generation cephalo-
sporin and a subcutaneous injection of low-molecular-weight heparin sodium for
deep venous thrombosis prophylaxis.
The postoperative course of each patient was closely monitored. On the day of
ﬂatus passage and oral food intake, the duration of nasojejunal decompression,
postoperative perfusions, and length of hospital stay were recorded. Mortality,
abdominal complications (abscesses ﬁstulas, generalized peritonitis, and wound
complications), pulmonary complications (pneumonia and atelectasis), post-
operative fever, nausea, and vomiting, and discomfort from the NJT (pain, nasal
soreness, and painful swallowing) were evaluated. Postoperative mortality included
death within the ﬁrst 30 days after surgery or during the original hospital stay.
Fistula was deﬁned as a proven leak of water-soluble contrast material during
a radiographic examination, or a leak of clinical signiﬁcance necessitating reopera-
tion. Postoperative fever was deﬁned as the body temperature higher than 38 C
taken at least 12 h after operation. Intravenous perfusions were maintained until
resumption of oral feeding. As reported by the patient, the degree of discomfort from
the NJT was graded on a scale from 0 to 3 (absence of discomfort or slight, moderate,
or severe discomfort). For patients who could not tolerate food, TPN was started
7 days after their operation. Table 1 demonstrates patients demographic and
operative characteristics.
3. Results
The Chi-square test did not indicate any statistically signiﬁcant
differencebetweenthe twogroups regarding tumor location(Table2).
In group I, the mean time for the passing of initial gas was
2.61.1 days, postoperatively, and in group II it was 2.831.04
days, postoperatively. The ManneWhitney test did not indicate any
statistically signiﬁcant difference between the two groups.
The mean time for the postoperative liquid diet was 6.3 0.4 in
group I and 61.4 days for group II, which did not indicate any
statistical difference between the two groups.
In group I, the mean time of hospitalization was 9.71.3 days
and in group II it was 9.3 2 days, which did not indicate any
statistical different between the two groups.
Postoperative bloating was seen in ﬁve patients (20%) in group I
and in six patients (24%) in group II. There was no signiﬁcantTable 2
Tumor location in the studied patients.
Tumor location Without NJT With NJT
N (%) N (%)
Upper third proximal 10 (40%) 5 (20%)
Middle third proximal 5 (20%) 4 (16%)
Lower third proximal 2 (8%) 1 (4%)
Diffuse 1 (4%) 2 (8%)
Proximal and middle 4 (16%) 7 (28%)
Lower and middle 3 (12%) 6 (24%)
Total 25 (100%) 25 (100%)difference between the two groups according to the Fisher’s exact
test (P¼ 0.718). Chart 1 demostrotes percent of bloating in patients
with NJT and without NJT.
In group I, the mean pain score postoperatively on the third day
was 3.351.26 and in group II it was 3.10.85. On the sixth day,
postoperatively, the average pain score was 1.3 6 in group I and
1.29 0.6 in group II and there was no signiﬁcant difference
between the two groups. Chart 2 demonstrates pain score at 3rd
and 6th day after operative in both group.
The prevalence of sore throat, speech disorder, headache, cough,
and drying of the oral mucosa was signiﬁcantly higher in group I.
Three patients in group I and two patients in group II had
a postoperative fever. Moreover, two patients in group I had nasal
skin necrosis. All of the patients were asked about discomfort due
to the use of the NJT and the score was from 0 to 3 (0: without
discomfort, 1: mild, 2: moderate, 3: severe). The mean score was
2.421.57.
Only onemajor complication occurred in both groups. Each group
had a patient with ﬁstula resulting from esophagojejunostomy
anastomosis to the skin (enterocutaneus ﬁstula) (P value <0.05).
Table 3 demonstrates morbidity rate in two groups.Chart 2. Pain score at 3rd and 6th day after operation in both groups.
Table 3
Morbidity rate in two groups.
Complains and signs about NJT Without NJT With NJT P-value
N (%) N (%)
Sore throat 1 (4%) 12 (48%) <0.001
Nasal disorder 0 (0%) 2 (8%) <0.001
Speech disorder (temporary) 0 (0%) 18 (72%) <0.001
Dry oral mucosa 4 (16%) 10 (40%) <0.05
Nasal skin necrosis 0 (0%) 2 (8%) <0.05
Fever 3 (2%) 4 (16%) 0.041
Cough 2 (8%) 4 (16%) <0.041
Headache 2 (8%) 6 (24%) 0.023
Vomiting 4 (16%) 3 (12%) 0.791
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Nasogastric and nasojejunal tubes in gastrectomy are used in
most abdominal operations, but its importance has been under
question in recent decades. In some cases its disadvantages are
more than its advantages; thus, it seems that there is no need to use
the NJT long term after total gastrectomy. Advocators of the NJT
believe that it leads to improved GI motility, early feeding, less
abdominal complaints and the protection of the esophagogastric
anastomosis; but others have noted its complications and reported
that its beneﬁts are under question.
This study was performed on 50 patients who underwent a total
gastrectomy. They were randomly divided into two groups: with
a NJT (25 patients) and without a NJT (25 patients). In the ﬁrst
group, the nasojejunal tube remained until GI motility returned to
normal. In the other group, the nasojejunal tubewas not inserted or
removed immediately after surgery. The two groups were similar
regarding age, sex, weight, and height. The present study showed
that there is no need for the insertion of the NJT after gastrectomy.
A meta-analysis study performed by Cheatham et al. in 1995 on
nasogastric decompression after elective laparotomy, evaluated
3964 patients. Days of ﬁrst oral intake were signiﬁcantly less, and
pulmonary complications and postoperative fever were signiﬁ-
cantly lower in patients without the NJT.12 Ten years later Nelson
et al. published themost recentmeta-analysis that partly conﬁrmed
these results. Patients not having a nasogastric tube experienced an
earlier return of bowel function and a marginal decrease in wound
infection and ventral hernia; however, anastomotic leakage was
similar in the two groups. As a result, they concluded that routine
nasogastric decompression should be avoided.13
Only a few studies have evaluated the efﬁcacy of nasojejunal
decompression after gastrectomy. The ﬁnding of this study is in
accordance with the results of three prospective studies from far
eastern centers with a high sample size in Taiwan and Korea.14e16
These studies have suggested that there is no need for a nasojeju-
nal tube after gastrectomy. Yoo et al. performed a prospective study
on 136 patients that underwent a radical gastrectomy for cancer.
They found that the time of the passage of ﬂatus, time to begin
a liquid diet, and postoperative hospitalization were signiﬁcantly
shorter in the no-decompression group.15 In addition, they showed
that the postoperative insertion of theNJTwas associatedwithdelay
in beginning oral intake and a longer hospital stay.15 In our study, no
difference in these parameters was observed between the two
groups. Akbaba et al. in Turkey (2004) performed a study on 66
patients who underwent a total gastrectomy. They concluded that
gastrointestinal complications such as bloating and vomiting were
similar in both groups with and without the NJT, but fever and
pulmonary complications were higher in the NJT group.17
In the present study, complications of the nasojejunal tube,
such as sore throat, nasal discomfort, temporary speech disorders,and patients’ dissatisfaction were signiﬁcantly higher in the NJT
group.
Chang et al. performed a study in 2003 on 300 patients who had
undergone gastrectomy. There was a statistically signiﬁcant differ-
ence between the two groups in terms of patients’ discomfort. The
main complainswere sore throat and sleep disorders, so insertion of
the nasogastric tube during operation and removing it after opera-
tion can be recommended.18 Carrire et al. in 2007 reported that
complains related to the NJT were moderate to severe in 72% of
patients after a total gastrectomy.19 Since gastrectomy and lym-
phadenectomy cause wide dissection in the upper abdomen and
denervation of neurotic ﬁbers in sympathetic and parasympathetic
nerves, many surgeons believe that decompression by the NJT is
needed after gastrectomy because it prevents ileus and protects the
anastomosis. On the other hand, in recent decades some studies
have reported that the insertion of the NJT after gastrectomy causes
complications and problems for the patient. The present study
showed that the insertion of the NJT after gastrectomy did not have
any effect in the prevention of anastomosis; moreover, it caused
complications and discomfort for the patient, so we would not
recommend using the NJT after gastrectomy.
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